Printer Friendly

Competitive Technologies, Inc. Reports Patent Issued for Diagnosing And Treating Male Impotence

Represents Univ. Of Arizona As Exclusive Licensing Agent For Technology

FAIRFIELD, Conn., Nov. 26 /PRNewswire/ -- Competitive Technologies, Inc. (AMEX: CTT) today announced the issuance of U.S. Patent No. 5,576,290 entitled "Compositions and Methods for the Diagnosis and Treatment of Psychogenic Erectile Dysfunction." CTT represents the University of Arizona as the exclusive licensing agent for this technology. The invention utilizes a peptide hormone analog designed by professors at the University of Arizona to diagnose and treat psychogenic erectile dysfunction in impotent men. It is estimated that there are over 100 million men worldwide who suffer from impotence.

CTT is currently working with the University of Arizona to locate a licensee with financial capability and technical resources to take the peptide through the regulatory process and into the marketplace.

The University of Arizona invention provides the only known patented method for the rapid and precise differentiation of physiological and psychological impotence. It is anticipated that this invention will allow the general practitioner to make an immediate differential diagnosis of a patient's problem, without referral to a specialist. The psychogenically impotent men responding to the drug can then be therapeutically treated. A recently concluded clinical study demonstrated increased effectiveness and safety over other known drug therapies for impotence. In addition, the drug does not require direct penile injection.

Dr. Mac Hadley, who is the inventor and a member of the Department of Anatomy at the University of Arizona, commented, "Presently most impotent men have no recourse other than to be treated by default -- though direct penile injection -- as if they have organic (physiological) erectile dysfunction. The present technology will be a salvation for the millions of men with psychogenic impotence."

Competitive Technologies, Inc. -- based in Fairfield, CT, with offices in Bethlehem, PA; Cleveland, OH; Osaka, Japan; And London, England -- is in the technology transfer business concentrating primarily on the commercialization and licensing of high-tech company and university research. Additional information about CTT can be found on its web-site:

SOURCE Competitive Technologies, Inc.
 -0- 11/26/96

/CONTACT: Robert Siegel, General Counsel of Competitive Technologies, Inc., 203-255-6044, or fax, 203-254-1102, or; or J. Desmond Towey, or George N. Robinson, both of Desmond Towey & Associates, 212-888-7600, or fax, 212-888-7686/


CO: Competitive Technologies, Inc.; University of Arizona ST: Connecticut, Arizona IN: MTC SU: PDT

PD -- NYTU010 -- 4058 11/26/96 06:15 EST
COPYRIGHT 1996 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 26, 1996
Previous Article:UPS Offers Consumers Tips on Holiday Gift Mailing; Thursday, December 19, Peak Shipping Day
Next Article:Eisai Receives FDA Marketing Clearance for ARICEPT (donepezil hydrochloride), A New Treatment For Alzheimer's Disease

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters